Point72 Asset Management
SMMT icon

Point72 Asset Management’s Summit Therapeutics SMMT Stock Holding History

Point72 Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.9M Buy
3,697,803
+2,913,617
+372% +$51.7M 0.06% 406
2026
Q1 		$14.9M Buy
+784,186
New +$12.7M 0.02% 986
2019
Q1 		– Sell
-445,991
Closed -$513K – 1216
2018
Q4 		$513K Sell
445,991
-18,639
-4% -$29K ﹤0.01% 872
2018
Q3 		$1.03M Sell
464,630
-262,090
-36% -$604K ﹤0.01% 845
2018
Q2 		$1.78M Sell
726,720
-23,280
-3% -$298K 0.01% 765
2018
Q1 		$9.68M Sell
750,000
-35,600
-5% -$445K 0.04% 435
2017
Q4 		$8.7M Sell
785,600
-20,871
-3% -$233K 0.04% 475
2017
Q3 		$10.1M Buy
806,471
+5,240
+0.7% +$67.9K 0.05% 393
2017
Q2 		$9.13M Hold
801,231
– – 0.05% 407
2017
Q1 		$10.6M Sell
801,231
-124,968
-13% -$1.45M 0.06% 391
2016
Q4 		$7.93M Hold
926,199
– – 0.06% 361
2016
Q3 		$8.39M Hold
926,199
– – 0.06% 312
2016
Q2 		$7.49M Sell
926,199
-3,800
-0.4% -$30.9K 0.05% 350
2016
Q1 		$6.34M Sell
929,999
-1
-0% -$8 0.05% 387
2015
Q4 		$10.7M Buy
930,000
+10,361
+1% +$108K 0.09% 273
2015
Q3 		$9.57M Buy
919,639
+7,736
+0.8% +$92.7K 0.08% 309
2015
Q2 		$9.63M Buy
911,903
+68,603
+8% +$777K 0.07% 331
2015
Q1 		$10.4M Buy
+843,300
New +$9.55M 0.07% 322

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management's SMMT Position: Q2 2026 in Review

Point72 Asset Management increased its Summit Therapeutics (SMMT) stake by 372% in Q2 2026, buying an estimated $51.7M and bringing the position to 3,697,803 shares worth $53.9M. The position accounts for 0.06% of the portfolio, ranked #406.

Point72 Asset Management first reported a position in SMMT in Q1 2015 and has held it in 18 quarters since. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Point72 Asset Management held 3,697,803 shares of Summit Therapeutics worth $53.9M as of Q2 2026.
  • Point72 Asset Management bought 2,913,617 Summit Therapeutics shares in Q2 2026, an estimated $51.7M.
  • Summit Therapeutics made up 0.06% of Point72 Asset Management's portfolio in Q2 2026, its #406 holding.
  • Point72 Asset Management first reported a position in Summit Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.